Fluor to Offer EPCM Services for a Billion-Dollar Project in Indiana

Group 1: Core Insights - Fluor Corporation has secured a letter of intent from a leading pharmaceutical maker, marking its second multi-billion-dollar contract win in 2023 [1] - The project involves providing engineering, procurement, and construction management (EPCM) services for a facility in Lebanon, IN, dedicated to manufacturing peptide-based drugs for Type 2 diabetes and weight control, representing the largest investment in an active pharmaceutical ingredient facility [2][3] - Fluor's president highlighted the project as one of the largest life science initiatives ever undertaken, reinforcing the company's leadership in the EPCM sector [3] Group 2: Business Strategy and Performance - Fluor has been implementing a "Building a Better Future" strategy for over four years, focusing on growth outside traditional oil and gas sectors, pursuing fair commercial contracts, and maintaining financial discipline [4] - The company's backlog reached $28.5 billion at the end of 2024, with 80% being reimbursable contracts, indicating a strong demand for its services moving into 2025 [5] - Despite a year-to-date decline of 24.6% in shares, Fluor's diversified business portfolio is expected to position it well for future opportunities [7]